|Articles|May 4, 2006

2006 Conference Statistics

Author(s)BioPharm International Editors

Data from recent Biotech/Pharmaceutical Industry Conference/Events

To view a PDF of this article from the BioPharm International archives, click this link

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content

Behind the Headlines Episode 30: 2026 Wish List

ByChris Spivey

December 17th 2025

Sterile insulin pen. Ozempic, semaglutide, wegovy medical device. Diabetes, obesity treatment. Portable injection system, precision needle, ergonomic design. Pharmaceutical industry, healthcare 3D | Image credit: © Corona Borealis - © Corona Borealis - stock.adobe.com

EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery

ByFeliza Mirasol

December 16th 2025

A 3d rendering of the moment a nanocarrier or liposome delivers its therapeutic payload to a specific target or nervous system at a microscopic level. | Image Credit: ©Love Employee -stock.adobe.com

Achieving Targeted Delivery of Biologics with Nanoscale Systems

ByCynthia A. Challener

December 16th 2025

Isometric global cargo logistic website background design. Maritime, air shipping transport logistic, warehouse storage concept, export, import, trading, cargo international delivery, distribution. 3D | Image credit: © Corona Borealis - © Corona Borealis - stock.adobe.com

FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model

ByFeliza Mirasol

December 15th 2025

FAQ: Shifts in FDA Regulations and Strategies in 2025

ByPatrick Lavery

December 15th 2025

2006 Conference Statistics

Newsletter

Related Content

Behind the Headlines Episode 30: 2026 Wish List

EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery

Achieving Targeted Delivery of Biologics with Nanoscale Systems

FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model

FAQ: Shifts in FDA Regulations and Strategies in 2025

Trending on BioPharm International

FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model

EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery

Charles River Incubator Cohort to Accelerate CGT Development

Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring

Developing Next-Gen Cell Lines Using Targeted Integration